Citadel Advisors’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-107,555
Closed -$67.6K 15410
2023
Q2
$136K Buy
+107,555
New +$174K ﹤0.01% 10482
2023
Q1
Sell
-5,535
Closed -$10.4K 15821
2022
Q4
$7.31K Buy
+5,535
New +$7.07K ﹤0.01% 13834
2022
Q3
Sell
-13,031
Closed -$13K 13911
2022
Q2
$13K Buy
+13,031
New +$17.2K ﹤0.01% 12528
2022
Q1
Sell
-18,420
Closed -$40K 14881
2021
Q4
$40K Sell
18,420
-13,530
-42% -$45K ﹤0.01% 13373
2021
Q3
$119K Sell
31,950
-18,285
-36% -$78K ﹤0.01% 12659
2021
Q2
$300K Buy
50,235
+35,218
+235% +$186K ﹤0.01% 11280
2021
Q1
$99K Sell
15,017
-1,894
-11% -$12.4K ﹤0.01% 12488
2020
Q4
$95K Buy
+16,911
New +$92.8K ﹤0.01% 10253
2020
Q3
Sell
-11,346
Closed -$80.5K 10934
2020
Q2
$132K Buy
+11,346
New +$135K ﹤0.01% 8829
2018
Q4
Sell
-4,794
Closed -$40K 9915
2018
Q3
$40K Buy
4,794
+3,007
+168% +$31.7K ﹤0.01% 8853
2018
Q2
$22K Buy
+1,787
New +$18.4K ﹤0.01% 8632
2018
Q1
Sell
-4,545
Closed -$60K 8929
2017
Q4
$60K Buy
4,545
+314
+7% +$4.04K ﹤0.01% 7578
2017
Q3
$62K Sell
4,231
-7,055
-63% -$712K ﹤0.01% 7143
2017
Q2
$1.18M Buy
11,286
+3,874
+52% +$416K ﹤0.01% 3855
2017
Q1
$950K Buy
7,412
+4,698
+173% +$495K ﹤0.01% 4078
2016
Q4
$243K Sell
2,714
-1,589
-37% -$120K ﹤0.01% 6000
2016
Q3
$316K Buy
+4,303
New +$311K ﹤0.01% 5595
2015
Q4
Sell
-56,915
Closed -$3.94M 9329
2015
Q3
$3.94M Buy
56,915
+50,091
+734% +$4.7M ﹤0.01% 2188
2015
Q2
$623K Buy
6,824
+3,059
+81% +$310K ﹤0.01% 4638
2015
Q1
$415K Buy
+3,765
New +$442K ﹤0.01% 5210
2014
Q2
Sell
-7,563
Closed -$1.36M 8395
2014
Q1
$1.36M Buy
+7,563
New +$1.38M ﹤0.01% 3040

Other funds holding ARAV

Citadel Advisors's ARAV Position: Q3 2023 in Review

Citadel Advisors sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 107,555 shares — an estimated $67.6K sold.

Citadel Advisors first reported a position in ARAV in Q1 2014 and held it in 21 quarters. The position peaked at $3.94M in Q3 2015. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • Citadel Advisors reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 107,555 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $67.6K.
  • Citadel Advisors first reported a position in Aravive, Inc. Common Stock in Q1 2014 and held it in 21 quarters.
  • Citadel Advisors's Aravive, Inc. Common Stock position peaked at $3.94M in Q3 2015.
  • 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.